baber/WOPTO huggingface dataset:
Patent CA-2482664-A1 (CA)
Inventor: BEN-HAIM NIV
IPC: B42F13/04
Filed: 2004-10-21
Abstract: A notebook including a stack of papers and a front and back covers having generally the same overall sire as stack of papers, the front cover including a window and a printed paper wheel assembly, allowing the wheel to rotate freely while exhibiting images through the window. The notebook further includes a binding mechanism binding the stack of papers and the front and back covers together, wherein at least part of the binding mechanism extends through the stack of papers and covers to bind stack of papers and covers.
Patent CA-2483569-A1 (CA)
Inventor: ARONHIME JUDITH
IPC: C07C211/42
Filed: 2003-04-29
Abstract: Provided are processes for preparation of crystalline sertraline hydrochloride form II substantilly free of other polymorphic forms of sertraline hydrochloride, preferably on an industrial scale.
Patent CA-2483744-A1 (CA)
Title: Multiple imaging system and method for designing same
Inventor: TOCCI NORA C
IPC: A61B17/00
Filed: 2003-03-13
Abstract: An optical system of the present invention produces multiple simultaneous adjoining images on a single image plane. The optical system includes a firs t optical sub-system (12), a second optical sub-system (14), an aperture stop (16) located between the first and second optical sub-systems, and a beam separating sub-system (18) located at a plane substantially coincident with the aperture stop. The beam separating sub-system can receive electromagneti c radiation from the first optical sub-system and can separate the received electromagnetic radiation into multiple beams of electromagnetic radiation. The second optical sub-system images the multiple beams of electromagnetic radiation received from the beam separating sub-system into multiple images on an image plane (28).An output filter, overlaid on the image plane, prevents light from any one of the images from passing through to the portion of the image plane corresponding to any one of the other images.
Patent CA-2485487-A1 (CA)
Inventor: ARANYI ERNIE
IPC: A61B17/00
Filed: 2003-05-16
Abstract: L'invention concerne un applicateur (10) destiné à une matière de fermeture de plaie. Cet applicateur comprend un ensemble de préhension (12) pourvu d'une poignée mobile, une partie corps (14) s'étendant distalement à partir de l'ensemble de préhension et un ensemble embout (16) porté adjacent à l'extrémité distale de la partie corps. L'ensemble embout comprend un boîtier (78) définissant un trou, un élément embout et un élément joint (84). Le boîtier de l'ensemble embout définit un canal d'entrée (88) et un siège de valve (82a) adjacent à la sortie du canal d'entrée. L'élément joint est distalement mobile dans l'orifice du boîtier d'une position fermée, dans laquelle l'élément valve (82) est contigu au siège de valve (82a), à une position ouverte, dans laquelle l'élément valve est distant du siège de valve. L'ensemble embout est configuré de telle manière que le mouvement de l'élément joint de la position ouverte à la position fermée entraîne une réduction de la pression qui règne dans un canal de décharge de l'ensemble embout pour réduire au minimum la fuite goutte à goutte de la matière de fermeture de plaie de l'applicateur.
Patent CA-2486914-A1 (CA)
Title: Mitigation of proppant sticking in removing downhole tools
Inventor: CORONADO MARTIN P
IPC: E21B43/267
Filed: 2003-05-21
Abstract: It has been discovered that sticking caused by proppants used in a frac pack or gravel pack operation during hydrocarbon recovery efforts can be mitigated by placing a proppant anti-sticking fluid in a downhole space, such as an annulus adjacent a tool system or service tool. An operation is conducted that involves passing a carrier fluid including a proppant through the tool system.  The carrier fluid is gelled and optionally crosslinked. The proppant anti-sticking fluid is flushed through the tool'system to break the gel, contact the proppant and substantially clear the proppant from the tool system.  Finally, the tool system is removed from downhole. The proppant anti-sticking fluid includes a diluent, such as an aqueous fluid, a brine, or a non-aqueous fluid, and an effective mount of a gel-breaking component to break the gel, and may, but does not necessarily include a surface tension-reducing compound, such as a surfactant.
Patent CA-2487656-A1 (CA)
Title: Emergency call handling in a voice-over-packet environment
Inventor: CARON GUY
IPC: H04M11/06
Filed: 2004-11-12
Abstract: A method of routing an emergency call received at a network element. The method comprises determining a directory number associated with a communication device having originated the emergency call, consulting a local database to obtain routing information associated with the directory number, and directing the call and the routing information over a path dedicated to emergency calls. Also, a network element which comprises the database as well as a control entity, the control entity being operative for receiving an incoming call originated by one of the communication devices, determining the directory number associated with the communication device having originated the call, determining whether the call is an emergency call and, responsive to the call being an emergency call, accessing the database to obtain the routing information related to the directory number and directing the call as well as the routing information over a trunk group dedicated to emergency calls.
Patent CA-2489446-A1 (CA)
Title: Ribonuclease zymogen design
Inventor: FUCHS STEPHEN M
IPC: C12N9/22
Filed: 2003-06-13
Abstract: An enzyme is re-engineered to be a zymogen, an enzyme precursor which is converted into an enzyme by protease cleavage. In the example described here , an RNase A enzyme is converted into a zymogen by adding to the enzyme a brid ge of amino acids linking the amino and carboxyl termini of the enzyme. The bridge has built in it a protease cleavage site for a specific protease, for example the protease plasmepsin II, produced by the malaria parasite. Since RNase A can be made cytotoxic, this permits a cytotoxic enzyme to be made in the form of a zymogen that becomes active only when it is acted on by a protease only present in a particular target cell such as a pathogen.</SDOAB >
Patent CA-2489860-A1 (CA)
Title: Use of an antibody against s100a8 or s100a9 as chemotactic factor inhibitor for modulating inflammatory reactions
Inventor: TESSIER PHILIPPE A
IPC: A61K38/17
Filed: 2003-06-20
Abstract: The present invention relates to compounds and methods for modulating, reducing or inhibiting, inflammatory reactions in a patient. Particularly, inflammatory reactions that are targeted by the present invention are cell migration, secretion of toxic products and proteolysis at a site of inflammation. Reduction of inflammation manifestations and reactions occurs by using an anti-S100 polynucleotide or polypeptide inhibitor or antagonist, which is essentially targeted against S100A8, S100A9 or S100A12, alone or in combination with other inhibitors of chemokines or immune modulating products.
Patent CA-2492280-A1 (CA)
Inventor: ISSBERNER ULRICH
IPC: C11D17/04
Filed: 2003-07-08
Abstract: This invention concerns products for cleansing and other applications, which products comprise an applicator such as a puff (pouf), pad, sponge, cotton ball, swab, brush, glove, mitt or bar, to which a lipid and aqueous phase ha ve been applied and which products have been dried afterwards. The invention further concerns the manufacture and use of such products.
Patent CA-2492924-A1 (CA)
Title: Nouveaux derives de piperazinyl-pyrazinone pour le traitement des troubles lies au recepteur 5-ht2a
Inventor: THOR MARKUS
IPC: C07D241/18
Filed: 2003-06-25
Abstract: La présente invention concerne des composés de la formule générale (1) dans laquelle m, n, R?1¿, R?2¿, R?3¿ et R?4¿ sont tels que définis dans le descriptif. L'invention se rapporte également à des compositions pharmaceutiques comprenant lesdits composés, à des procédés de préparation de ces derniers, et à l'utilisation desdits composés dans la préparation d'un médicament destiné au traitement des troubles ou états médicaux liés au récepteur 5-HT¿2A?.
Patent CA-2493225-A1 (CA)
Inventor: VENET MARC GASTON
IPC: A61K31/5377
Filed: 2003-07-18
Abstract: L'invention concerne de nouveaux dérivés substitués de quinoléine représentés par la formule (Ia) ou la formule (Ib), leurs sels d'apport basique ou acide acceptables sur le plan pharmaceutique, leurs formes isomères sur le plan stéréochimique, leurs formes tautomères et leurs formes N-oxyde. Ces composés sont utiles pour traiter des maladies mycobactériennes, en particulier, les maladies provoquées par des mycobactéries pathogènes, telles que mycobacterium tuberculosis, M. bovis, M. avium et M. marinum. Dans ces composés, R?1¿ représente brome, p=1, R?2¿ représente alkyloxy, R?3¿ représente naphtyle ou phényle éventuellement substitués, q=1, R?4¿ et R?5¿ indépendamment chacun représentent hydrogène, méthyle ou éthyle, R?6¿ représente hydrogène, r est égal à 0 ou 1 et R?7¿ représente hydrogène. L'invention concerne également une composition comprenant un véhicule acceptable sur le plan pharmaceutique et, en tant qu'ingrédient actif, une quantité thérapeutique efficace de ces composés, la mise en application de ces composés ou de ces compositions afin de préparer un médicament servant à traiter des maladies mycobactériennes et un procédé servant à préparer ces composés.
Patent CA-2496048-A1 (CA)
Title: Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer
Inventor: VALK PETER JACOBUS MARIA
IPC: C12Q1/68
Filed: 2003-08-14
Abstract: The present invention relates to murine genomic regions, identified by retroviral insertional tagging of mice as being involved in tumor developmen t, in particular leukemia development, as well as human homologues thereof, and to the use of these genomic regions for the identification and development o f anti-cancer drugs, such as small molecule inhibitors, antibodies, ribozymes, antisense molecules and RNA interference (RNAi) molecules, that are effectiv e in reducing or eliminating the tumorigenic effects of genetic transformation s in these genomic regions and/or eliminating the tumorigenic effects of expression products thereof. The invention further relates to these anti- cancer drugs and to their use as pharmaceutical reagents for the treatment o f cancer, as well as to pharmaceutical compositions comprising one or more of said pharmaceutical reagents and to methods for the treatment of cancer usin g said pharmaceutical compositions, in particular to methods of gene therapy. In yet further aspects, the invention relates to nucleic acids, to antibodies capable of binding specifically to murine genomic regions and to expression products thereof, to the use of said nucleic acids or antibodies as diagnost ic reagents for the diagnosis of cancer, as well as to diagnostic compositions comprisingone or more of said diagnostic reagents and to methods for the diagnosis of cancer using said diagnostic compositions.
Patent CA-2496191-A1 (CA)
Title: Transmission casing for bicycle
Inventor: YASUDA KAZUTOYO
IPC: B62M11/14
Filed: 2005-02-08
Abstract: The present invention provides a transmission casing for a bicycle which has the sufficient strength and rigidity and has the simple structure while capable of hermetically sealing a transmission body of the bicycle. In a transmission casing for a bicycle in which a transmission body of a bicycle is covered with a casing and a plurality of transmission shafts are supported by the casing, the transmission casing is constituted of a light-metal-made reinforcing member made of aluminum, a light alloy or the like which supports shaft portions of the plurality of transmission shafts, and a fiber- reinforced-plastic-made cover member which is integrally laminated to an inner surface of the light-metal-made reinforcing member so as to hermetically seal the transmission body, the light-metal-made reinforcing member has a strength necessary for supporting the plurality of transmission shafts, and the fiber-reinforced-plastic-made cover member has a residual rigidity by subtracting rigidity obtained by the metal-made- reinforcing member from rigidity necessary for preventing the deformation of the whole casing.
Patent CA-2496649-A1 (CA)
Title: Method and apparatus for isolating and testing zones during reverse circulation drilling
Inventor: LIVINGSTONE JAMES I
IPC: E21B47/01
Filed: 2005-02-10
Abstract: A zone isolating and testing apparatus comprising an isolation tool and a downhole flow control means and a method of using such apparatus is disclosed. The zone isolating and testing apparatus is particularly useful for testing zones during reverse circulation drilling using concentric drill string such as concentric drill pipe or concentric coiled tubing. The isolation tool of the zone isolating and testing apparatus comprises an expandable packer means and is adapted to connect to concentric drill string near the drilling means. The downhole flow control means of the zone isolating and testing apparatus comprises two valves, one for closing off the annulus between the inner tube and outer tube of the concentric drill string and the other for closing off the inner space of the inner tube. The downhole flow control means is also adapted to connect to concentric drill string near the drilling means. During testing, the isolation tool seals off the annulus between the concentric drill string and the walls of the wellbore and the downhole flow control means seals off either the annulus between the inner tube and outer tube of the concentric drill string or the inner space of the inner tube of the concentric drill string.
Patent CA-2496867-A1 (CA)
Title: Therapeutic treatment methods
Inventor: AUCI DOMINICK L
IPC: A61K31/56
Filed: 2003-08-28
Abstract: The invention relates to the use of compounds to ameliorate or treat an condition such as a cystic fibrosis, neutropenia or other exemplified conditions. Exemplary compounds that can be used include 3.beta.-hydroxy- 17.beta.-aminoandrost-5-ene, 3.beta.-hydroxy-16.alpha.-fluoro-17.beta.- aminoandrost-5-ene, 3.alpha.-hydroxy-16.alpha.-fluoro-17.beta.-aminoandrost- 5- ene, 3.beta.-hydroxy-16.beta.-fluoro-17.beta.-aminoandrost-5-ene, 1.alpha.,3.beta.-dihydroxy-4.alpha.-fluoroandrost-5-ene-17-one, 1.alpha.,3.beta., 17.beta.-trihydroxy-4.alpha.-fluorandrost-5-ene, 1.beta.,3.beta.-dihydroxy-6.alpha.-bromoandrost-5-ene, 1.alpha.-fluoro- 3.beta.,12.alpha.-dihydroxyandrost-5-ene-17-one, 1.alpha.-fluoro- 3.beta.,4.alpha.-dihydroxyandrost-5-ene and 4.alpha.-fluoro-3.beta.,6.alpha. , 17.beta.-trihydroxyandrostante.
Patent CA-2498784-A1 (CA)
Title: Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
Inventor: STHANAM NARAYANA
IPC: G16B30/00
Filed: 2003-09-15
Abstract: A bioinformatic method is provided for identifying and isolating proteins with MSCRAMM®-like characteristics from Gram positive bacteria, such as Enterococcus, Staphylococcus, Streptococcus and Bacillus bacteria, which can then be utilized in methods to prevent and treat infections caused by Gram-positive bacteria. The method involves identifying from sequence information those proteins with a putative C-terminal LPXTG (SEQ ID NO:1) cell wall sorting signal and other structural similarities to MSCRAMM® proteins having the LPXTG-anchored cell wall proteins. The MSCRAMM® proteins and immunogenic regions therein that are identified and isolated using the present invention may be used to generate antibodies useful in the diagnosis, treatment or prevention of Gram positive bacterial infections.
Patent CA-2504677-A1 (CA)
Title: Rendering digital content in a content protection system according to a plurality of chained digital licenses
Inventor: PARKS MICHAEL JAY
IPC: G06F12/14
Filed: 2005-04-21
Abstract: A request to render encrypted content is received and a chain of licenses corresponding to the content is located.      The chain includes a leaf license linked to the content at one end of the chain, a root license at the other end of the chain, and any intermediate licenses therebetween. The leaf license and any intermediate licenses in the chain are each bound to the adjoining license in the chain toward the root license, and the root license is bound to an owner of a private key (PR-U). For each license in the chain, the license is verified and it is confirmed that the license allows the content to be rendered. A decryption key is obtained from the leaf license based on application of (PR-U) to the root license, the obtained key is applied to decrypt the encrypted content, and the decrypted content is rendered.
Patent CA-2505099-A1 (CA)
Inventor: MONGOIN JACQUES
IPC: D06L3/12
Filed: 2003-11-05
Abstract: The use of a water-soluble copolymer (A) is claimed for improving the activation of optical brightening, where (A) is derived from at least one ethylenically unsaturated monomer (I) on which at least one alkoxy- or hydroxy-polyalkylene glycol function is grafted.  Independent claims are included for: (a) an agent for improving the activation of optical brightening, comprising at least one copolymer (A);  (b) methods for dispersing or milling minerals (B) in aqueous suspension, using (A);  (c) aqueous suspensions of dispersed or milled (B), which contain (A);  (d) methods for producing bulk fillers or coating slurries, using (A); and  (e) bulk fillers or coating slurries, which contain (A).
Patent CA-2507207-A1 (CA)
Inventor: ROHDE FLORIAN
IPC: A47J42/40
Filed: 2005-05-13
Abstract: Dispositif pour moudre des grains de café comprenant un mécanisme de moulin et un contenant de stockage disposé au-dessus de ce dernier, où le contenant de stockage est formé d'au moins deux compartiments pour des grains de café distincts, lesdits compartiments étant séparés par une partition, dans laquelle le fond du compartiment de stockage est muni d'une ouverture refermable par un rabat pivotant pour la sélection de l'alimentation en grains de café d'un des compartiments et/ou pour fermer l'orifice d'ouverture.  cet endroit, le rabat est de préférence supporté sur la partition de façon à pivoter. Ainsi, grâce au contenant de stockage, divers types de grains de café peuvent être envoyés de manière sélective vers le moulin.
Patent CA-2508649-A1 (CA)
Title: Unit dose packaging system (udps) having a child resistant locking feature
Inventor: JONES BRAD ALLEN
IPC: B65D5/43
Filed: 1999-08-24
Abstract: This invention relates to a two piece paperboard package that houses a unit dose product on an internal slide card within an outer paperboard shell. This package may have one or more internal or external lock(s) that prevent the slide card from being pulled out without triggering some type of lock release mechanism. This package is focused around providing a child resistant, senior-friendly unit dose package that can be opened and closed numerous times and then finally disposed of.
Patent CA-2509091-A1 (CA)
Title: System and method for handshaking between wireless devices and servers
Inventor: BRIGGS ROBERT D
IPC: H04L29/08
Filed: 2003-12-04
Abstract: A system, method, and computer program for data communication, or "handshaking," between wireless devices (12) and a server on a wireless network (70, 72). Upon a wireless device (12) communicating with the server (72), the server obtains data from the wireless device (12) indicative of wireless device attributes (82), and the server determines access of the wireless device, based upon the wireless device attributes (90), to applications either resident on that server or on other computer devices on the wireless network (114).
Patent CA-2511831-A1 (CA)
Inventor: TANG XIAOZHONG
IPC: A61K8/26
Filed: 2003-12-04
Abstract: L'invention concerne un sel d'aluminium sans zirconium (a) qui présente un rapport molaire aluminium/chlorure se situant entre 0,5 et 2,5 : 1 ; (b) qui comprend un matériau tampon contenant de l'azote en quantité telle que le rapport matériau contenant de l'azote/aluminium se situe entre 0,05 et 0,26 : 1, lequel matériau contenant de l'azote est choisi dans le groupe constitué d'un matériau tampon contenant de l'azote de la formule, dans laquelle n est un nombre situé entre 1 et 20 et chacun des R?1¿, R?2¿ et R?3¿ est indépendamment choisi dans le groupe comprenant hydrogène, méthyle et éthyle ; et (c) dont le sel présente un pH se situant entre 2 et 4 à une teneur de 15 % ; le sel étant exempt de tout autre matériau de piégeage halogéné et ayant une valeur d'au moins 0,50 pour le rapport calculé en tant que : zone Pic 5/zone totale sous Pic 2 + Pic 3 + Pic 4 + Pic 5.
Patent CA-2512697-A1 (CA)
Title: High resolution access control
Inventor: KUMAR MAHESH M
IPC: H04L12/56
Filed: 1999-10-22
Abstract: A system and method for high resolution access control for packetized information. A packet is received at a firewall. A rule corresponding to header information in the packet prescribes referring the packet to an access control proxy. The access control proxy analyzes the contents of the packet, and identifies a rule based upon the contents. The rule is implemented at the firewall.
Patent CA-2514067-A1 (CA)
Inventor: RYHAENEN TAPANI
IPC: G06K9/00
Filed: 2004-01-22
Abstract: The invention relates to an authentication arrangement, which is based on a capacitive fingerprint sensor. The invention also relates to a manufacturing method of such a fingerprint sensor. One essential idea in implementing this invention is to fabricate a capacitive fingerprint sensor on a plastic substrate (363) with an embedded integrated circuit chip (380). The invention also describes a way to create two or three dimensional forms for electrode structures (321, 322, 325, 365, 366) that can be used to optimize the performance of the sensor. When the three dimensional structure is designed to follow the shape of a finger, a very small pressure is required when sliding the finger along the sensor surface. This way the use of the sensor is ergonomic and the measurement is made very reliable. The inventive fabrication method describes the way, how to connect and embed an integrated circuit containing measurements electronics with a batch processed larger scale electrode configuration that is used for capturing the capacitive image of the fingerprint.
Patent CA-2514388-A1 (CA)
Title: Tissue expander, system and method
Inventor: GEDEBOU TEWODROS
IPC: A61B19/00
Filed: 2004-01-21
Abstract: Non-fluidized tissue expanders, tissue expender systems, and methods of expanding tissue are disclosed. The tissue expenders, systems, methods of the present invention incorporate an expandable encapsulated body mass implantable within the patient and operative to selectively expand to promote growth of an enlarged area of skin and subcutaneous tissue. Such tissue expansion is accomplished utilizing internal one or more distraction mechanisms disposed within the tissue expanders that are operative to expand by mechanical or electro-mechanical means. The present invention omits any type of inflatable body requiring the injection of fluids to effectuate expension of the tissue expender.
Patent CA-2520447-A1 (CA)
Inventor: RANDOLPH ROSS STEVEN
IPC: B65D51/16
Filed: 2004-04-01
Abstract: A cup (100) is provided having a lid (200) with a spout (300) defined by walls tapered towards a distal end of the spout. The lid has handles (400) extending therefrom that are preferably formed of a first and second material having different Shore A hardnesses to define a rigid portion (420) and a gripping portion (460).
Patent CA-2521422-A1 (CA)
Inventor: BABJAK JURAJ
IPC: C01G51/00
Filed: 2004-02-12
Abstract: La présente invention se rapporte à un procédé de lithiation à basse température d'hydroxydes et de formation d'oxydes métalliques lithiés ayant une cristallinité appropriée in situ. On ajoute du M(OH)¿2? dans une solution aqueuse de LiOH. On introduit un oxydant dans la solution qu'on chauffe à une température inférieure à 150 ·C et, si nécessaire, on remue. Le LiMO2 résultant cristallise in situ puis on l'enlève.